Pfizer strengthens AI drug discovery collaboration with equity investment September 26, 2022 AutoBot News 0 Pfizer and CytoReason have been partnered on artificial intelligence and machine learning technologies for drug discovery and development since 2019. The latest deal brings the companies closer.